Vimentin is an intermediate filament protein expressed by all mesenchymal tissues (Steinert and Roop, 1988) . Its function is still unclear, although it changes its structure during cell division from a cytoskeletal network during interphase, becoming hyperphosphorylated when entering mitosis (Evans and Fink, 1982; Chou et al., 1989) . This is followed by a complete reorganisation of the protein system (Aubin et al., 1980; Franke et al., 1984) .
Intermediate filaments, particularly vimentin, have been suggested to be DNA-binding proteins, and the sequence recognised by vimentin on DNA is homologous to the steroid hormone receptor sequence. Normally epithelial cells express keratins and not vimentin (Steinert and Roop, 1988) . This protein is expressed during neoplastic transformation and in some cases during cell culture, and in fact acquisition of vimentin expression has been shown in human breast carcinoma cell lines (Sommers et al., 1989; Thompson et al., 1992) , in coexpression with keratins in a human melanoma cell line (Hendrix et al., 1992) and in some leu.kaemic cells which have lost vimentin expression when they are committed to differentiate by different treatments (Paulin Levasseur et al., 1989; Jarvinen, 1990; Taimi et al., 1990; Tsuru et al., 1990; Aller et al., 1992) . The increase in vimentin expression is sometimes accompanied by a decrease in keratin expression (Sommers et al., 1992) .
The DNA sequences regulating the expression of vimentin have been cloned (Farrell et al., 1990; Hennekes et al., 1990; Stover and Zehner, 1992; de Klundert et al., 1992; Salvetti et al., 1993; Lilienbaum and Paulin, 1993) and certain proteins keep the gene silent when bound to DNA (Farrell et al., 1990; de Klundert et al., 1992; Salvetti et al., 1993) , while others such as the NFKcB protein, activate its expression . The simultaneous presence of both kinds of protein seems to result in inactivation of transcription (Salvetti et al., 1993 In a human breast cancer cell line made resistant to doxorubicin there was an increase in the expression of vimentin not detected in the wild-type cell line (Sommers et al., 1992) .
Considering the potential link between the acquisition of in vitro resistance to doxorubicin and the expression of vimentin, we tested two clones obtained from the human colocarcinoma cell line LoVo, with spontaneously different sensitivity to doxorubicin (Dolfini et al., 1992 Monti et al., 1993) .
This system offers a good model for studying whether vimentin expression is linked to the presence of P-glycoprotein or can also be detected in cells expressing a low level of P-glycoprotein-independent resistance to doxorubicin.
We evaluated the presence of vimentin at DNA, RNA and protein level in the two clones, one of which (clone 7) presents low-level resistance to doxorubicin, the drug being three times less active than in clone 5 and in LoVo WT (Dolfini et al., 1992 Monti et al., 1993) . For comparison we used a LoVo subline pharmacologically made resistant to doxorubicin (LoVo/DX), which expresses high levels of the mdr-l mRNA encoding for the P-glycoprotein, and presents a high level of resistance to doxorubicin (Grandi et al., 1986) .
Materias and metbods
Cell culture The human colocarcinoma cell line LoVo was grown in vitro in F12 medium supplemented with 10% fetal calf serum (Mascra Brunelli, Milan, Italy) and maintained at 37C in a 5% carbon dioxide incubator. The two clones 5 and 7, isolated from wild-type LoVo (LoVo WT), have been recently described (Dolfini et al., 1992 Monti et al., 1993) and were maintained in the same culture conditions. LoVo/DX cells were isolated after repeated treatment of LoVo WT cells with doxorubicin (Grandi et al., 1986).
DNA analysis Total genomic DNA was isolated from monolayer cultures of LoVo WT, LoVo clones 5 and 7 and LoVo/DX as described previously (Southern, 1975) , and digested to completion with the restriction endonuclease BamHI. Ten micrograms of DNA was separated on 0.8% agarose gel and transferred to a nylon membrane (Genescreen Phls, Dupont). Filters were baked for 2 h at 80C.
RNA anauysis
Total RNA was extracted with the guanidine isothiocyanate/ caesium chloride gradient method (Chirgwin et al., 1979) and size fractionated through 1% agarose gel containig 6.5% formakdehyde. The gel was then transferred to nylon membrane (Genescreen Plus, Dupont) and baked for 2 h at 80-C.
Hybridisation
Both RNA and DNA filters were prehybridised for 3-6 h in 50% formamide, 10% dextran sulphate, 1% SDS (sodium dodecyl sulphate), 1 M sodium chloride at 42-C. The filters were hybridised in the same buffer containing 100 g ml-' denatured salmon sperm DNA and 5 x 1O c.p.m. ml-' 3P-labelled probe. The probes were labelled with the Megaprime kit (Amersham) using the 1.2 kb BamHI fragment of human vimentin (Ferrari et al., 1986) subcloned into the Blhscript SK, the 1.3 kb EcoRI-Sall fragment of the human mdr-I gene (Gros et al., 1986 ) and the 1.3 kb PstI fragment of the murine £-actin gene.
DNA transfection
Cells from clone 5 were transfected with the calcium phosphate procedure. Human vimentin c-DNA under the control of cytomegalovirus (CMV) promoter (Sommers et al., 1992) was transfected together with a neomycin expression plasmid (pSV2Neo) to allow selection of positive colonies in geneticin (500 pg ml-'). Doxorubicin The samples were permeabilised with 0.5% Triton X-100 (Bio-Rad, CA, USA) in Hepes buffer (Hepes 20 mM, sucrose 300 mM, sodium chloride 50 mM, magnesum chloride 3 mM), 4 min at 4'C, then washed twice with PBS and twice with PBS-0. 1% BSA (bovine serum albumin). For vinculin labelhng at the cell-cell junction, cells were fixed for 5 mm in ice-cold methanol (-20 C) and then for lO s in ice-cold acetone (-20 C) .
Anti fixed in aceton at -20-C for 10min and stored at -20C until stained. For immunocytochemical staining, cytospin slides were incubated for 10min in 100ml of Tris buffer pH 7.6 containing 1 ml of hydrogen peroxide solution (36%) and 100mg of sodium azide to quench endogenous peroxidase, then rinsed in Tris pH 7.6 and treated with 1.5% horse serum for 20 min. Primary antibody was applied for 30 min at room temperature. Slides were then rinsed three times for 3min in 0.01% Triton X-100 in Tris. Biotinylated secondary antiserum was then applied for 30 min After rinses, the avidin-biotin-peroxidase complex was allowed to react for 30 min. Sections were incubated with diaminobenzidine-hydrogen peroxide for 1 min, washed in tap water, counterstained with Mayer's haematoxylin, dehydrated and mounted. A negative control was made for each sample by omitting the primary antibody.
Positively and negatively stained cells were counted in five high-power (x 400) fields randomly selected in each cytospin preparation. The boundaries of the field were marked out by a grid in the eyepiece. Two cytospin preparations were examinedifor each cell line. The results were expressed as the mean percentage of positive cells ± s.d.
Antibodies
Mouse anti-vimentin IgG and rabbit anti-keratins serum were obtained from Dako PAP Kit Systems (Dako, Carpinteria, CA, USA). Monoclonal anti-vinculin (ascitic fluid) was from Sigma and was used at 1:150 dilution. Rhodamineconjugated rabbit anti-mouse secondary antibodies were from Dakopatts (Glostrup, Denmark).
Res
LoVo clones 5 and 7 were selected from among many different clones obtained from LoVo WT, on the basis of the doxorubicin IC,1 (concentration inhibiting the growth of cells in vitro by 50%), which was respectively 16.8 and 48.9ng ml-', compared with 16.1 ngml' for LoVo WT . Thus, clone 7 has an intrinsically low level of resiance to doxorubicin, being three times more resistant than the parental cell line. For comparison, the ICEo of LoVo/DX for doxorubicin is about 50 times that of LoVo wr.
Clones 5 and 7 were analysed for the prsence of the mRNA for the md--l gene. Figure 1 shows a gel hybridised with the mdr-1 probe and reprobed with the actin gene to check for correct loading. LoVo Wr did not express appreciable levels of mdr-I mRNA which, however, was overexpressed in the LoVo/DX cells. mdr-l in clones 5 and 7 was imilar to LoVo WT. The lack of mdr-l overexpression in clone 7 confirmed previous reports of similar lels of doxorubicin uptake and efflux in clones 5 and 7 and LoVo Wr (Monti et a., 1993) . In LoVo/DX, which overexpresses the mdr-I mRNA, the efflux was much faster (Monti et al., 1993 ).
When we analysed the different cell lines for the expression of vimentn (Figure 2) (Figure 4 e-h).
Actin filaments crossing the cell cytoplasm were found when speamens were observed at a different focus (see Figure   4g ).
Vimentin staining gave similar results on cells at confluency ( Figure 5) . Only a few cells were positive for vimentin in LoVo WT confluent monolayers, and there are none in the field shown (Figure 5a ). There were more positive cells for vimentin in confluent monolayers of clone 5 (Figure 5b, T'he actin filament organisation at the cell borders observed at low density was more marked with cells grown to confluency (Figures 5 e-g ). This pattern, however, was almost mpletely lost in the LoVo/DX cell line (Figure 5h) After transfection of cells from clone 5 with vimentin cDNA, we selected seven clones which express vimentin mRNA differently (Table II) . The clones expressing vimentin at levels similar to those found in clone 7 did not have significantly different sensitivity to DX, each clone being as sensitive as, if not more than, the parental clone 5 from which they derive, independently on vimentin expression. The mRNA data were confirmed by immunofluorescence labelling of vimentin and clones expressing mRNA express protein as well (data not shown). Figure 4 Vimentin and actin detection on LoVo (a and e). clone 5 (b and f), clone 7-(c and g) and LoVo 'DX cells (d and h) (at low density) by double-immunofluorescence labelling. Cells were seeded on glass coverslips and cultured for 24 h. They were washed once. fixed and permeabilised (see Materials and methods section). Vimentin distribution (a-d) was detected by rhodamine fluorescence and actin distribution (e-h) by fluorescein fluorescence. Vimentin appears strongly stained on the majority of clone 7 and LoVo DX cells (c and d). whereas very few cells were positively stained in the LoVo parental and clone 5 lines (a and b, see arrows). Actin filaments were detected either at cell-cell boundaries, where they belong to the zonula adherens that contributes to cell-cell adhesion, or organised in stress fibres crossing the cells and terminating in focal contacts. At these sites they connect the cell with the substratum. The two different actin distributions were distinguished by focusing on different planes of the specimens. Bar = 20Lm-The mechanisms of drug resistance of cancer cells in vivo are still not clear. For anthracycine antibiotics, particularly doxorubicin, the major factor in vitro is the P-glycoprotein encoded by the mdr gene family (Endicott and Ling, 1989; van der Bliek and Borst, 1989) , which acts like a pump, removing the drug from the intracellular compartment. Other mechanisms involve the modification of topoisomerase II enzymatic activity, which is one of the targets of doxorubicin's action (Schneider et al., 1990; Zunino and , 1991) . Agents that block P-glycoprotein, such as calcium channel blockers, almost completely reverse the doxorubicin resistance of many resistant cancer cells (Ford and Hait, 1990) . However even when the intracellular drug levels are brought back to the same as in parental cells, a certain degree of resistance persists (Broggini et al., 1988; Ford and Hait, 1990) Many cells from confluent LoVo,/DX monolayers were recovered in the supernatant. This can be explained by the altered actin and vinculin organisation at the cell borders, supporting previous findings of altered distribution of cell junction molecules in cells expressing mdr (Sommers et al., 1992) .
The expression of vimentin has been reported to be accompanied by a loss of keratin expression (Paine et al., 1992; Sommers et al., 1992 
